Apple Inc. has launched a new challenge at the Patent Trial and Appeal Board, filing inter partes review petition IPR2026-00438 on August 17, 2026. At this early stage, the docket signals the opening of another high-stakes PTAB contest involving one of the most active technology companies in the patent arena. For practitioners tracking repeat PTAB filers, portfolio pressure campaigns, or parallel district court strategy, this is a proceeding worth watching.

The petitioner is Apple Inc.. Based on the currently available case information, Apple is seeking PTAB review of an issued patent, with the patent owner and the specific patent number expected to become clearer as the petition and related filings are further reflected on the docket.

The Third Circuit’s August 12, 2026 filing in No. 25-1673 is now available, but practitioners should approach it with one important caveat: the docket entry provided identifies the decision only as “Opinion,” without party names or a summary of the issues presented. That means the immediate practical takeaway is less about a specific substantive holding and more about monitoring the opinion closely for whatever procedural or doctrinal guidance it contains.

For lawyers who track appellate developments in the Third Circuit, even a routine opinion can matter.

The Department of Justice has announced a significant federal indictment in the Northern District of Georgia charging Zhu Chen, Jiayi Chen, and Jianjun Lu with forced labor, conspiracy to commit forced labor, and alien harboring. The case, brought as United States v. Zhu Chen, Jiayi Chen, and Jianjun Lu, underscores how federal prosecutors are continuing to pair labor-exploitation allegations with immigration-related charges in high-stakes criminal enforcement actions.

According to DOJ, the indictment alleges a combination of coercive labor practices and unlawful harboring of noncitizens.

The Federal Trade Commission has weighed in behind a proposal before the Ohio Supreme Court that would reduce the American Bar Association’s central role in determining which law schools qualify graduates for bar admission. While the change is specific to Ohio’s attorney-licensing framework, the implications are much broader: it touches the long-running debate over whether a single private organization should wield outsized influence over entry into the legal profession.

For decades, ABA accreditation has functioned as the default gatekeeper for many state bar systems.

The U.S. Department of Justice has opened a new front in federal-state immigration litigation, filing suits against New York, Connecticut, and Vermont over laws that allow certain undocumented students to qualify for in-state tuition rates and, in some cases, state financial aid. The federal government’s core argument is that these state policies conflict with federal restrictions on postsecondary education benefits tied to immigration status.

At the center of the dispute is the interaction between federal immigration law and state authority over public higher education.

The Fourth Circuit’s August 12, 2026 disposition in Nonprecedential Opinion, No. 25-4369, appears to be a routine unpublished appellate ruling, but it still offers a useful reminder for practitioners about the practical significance of nonprecedential decisions in federal appellate practice. Because the opinion is expressly designated nonprecedential, its legal force is limited: it resolves the dispute between the parties, but it does not establish binding circuit law in the way a published opinion would.

That distinction matters.

The Department of Justice has announced a major healthcare-fraud prosecution in Nevada, where a federal grand jury indicted physician Stephen Dubin, M.D., in connection with an alleged $95 million Medicare fraud scheme involving amniotic wound allografts. According to the government, the case centers on claims that medically unnecessary grafts were billed for elderly patients, making it one of the more significant recent criminal matters tied to Medicare reimbursement and wound-care products.

The allegations are notable both for their scale and for the product category involved.

A new post-grant review at the Patent Trial and Appeal Board could be one to watch for companies operating in the dental implant and broader medical-device space. On August 11, 2026, Straumann USA, LLC filed PGR2026-00070, asking the PTAB to review a recently issued patent.

A federal judge in Boston has again ruled against President Donald Trump’s executive order targeting mail voting, handing the administration another setback as it pushes for Supreme Court intervention before the November 3, 2026 midterm elections. U.S. District Judge Indira Talwani’s decision keeps in place a barrier to federal efforts that challengers say would reshape election administration by creating a federal voter list and drawing the U.S. Postal Service into election-related functions traditionally handled by states.

The ruling comes in consolidated litigation brought by voting-rights groups and Democratic state attorneys general, including League of Women Voters of Massachusetts et al v. Trump et al and State of California et al v. Trump et al in the District of Massachusetts.

A federal judge in Miami has thrown out a proposed settlement in President Donald Trump’s $10 billion lawsuit against the IRS, finding the case was pursued for an improper purpose and concluding that the deal itself could not stand. In a sharp rebuke, U.S. District Judge Kathleen Williams also referred Trump attorney Alejandro Brito and senior Justice Department officials to bar authorities for possible professional-conduct violations.

The rejected agreement reportedly would have provided unusually broad protections for Trump and established a compensation fund approaching $1.8 billion.

A new petition at the Patent Trial and Appeal Board, IPR2026-00413, was filed on August 14, 2026, and names Luxottica of America Inc. in the proceeding caption. For patent practitioners tracking activity in the eyewear, retail, consumer products, or branded technology spaces, this is a matter worth watching as the record develops.

At this early stage, the publicly available docket information identifies the proceeding title, filing date, and PTAB docket number, but key details that practitioners will want—most notably the patent number being challenged, the full party alignment between petitioner and patent owner, and the specific invalidity grounds asserted under 35 U.S.C. §§ 102 and/or 103—will likely become clearer as the petition and accompanying papers are added to the docket.

That said, the filing itself is significant.

The Justice Department’s Civil Rights Division has announced a $3.2 million settlement with OpenAI OpCo LLC and Statsig Inc. over allegations that the companies discriminated against U.S. workers. The resolution is notable not only because it involves a major AI company, but also because it underscores the government’s continued focus on employment practices at the intersection of immigration law, recruiting, and workforce compliance.

While the public attention around AI companies often centers on data use, intellectual property, and product liability, this matter is a reminder that hiring practices remain a significant enforcement risk.

A new post-grant review petition has been filed at the Patent Trial and Appeal Board against Straumann USA, LLC, opening what could become a closely watched dispute for practitioners in the dental and medical-device patent space. The proceeding, PGR2026-00070, was filed on August 11, 2026. View full case on Docket Alarm

At this early stage, the PTAB docket identifies Straumann USA, LLC in the case caption, but practitioners will want to watch the filing record closely to confirm the specific patent number at issue, the named petitioner, and the precise claims challenged once the petition and related papers are available through the docket.

The Justice Department’s recent public announcements underscore a familiar but increasingly urgent message for companies: federal enforcement remains active across corporate crime, fraud, and compliance-related matters, even during quieter stretches in the court-news cycle. Over the past several days and weeks, DOJ press activity has continued to highlight criminal prosecutions, civil enforcement actions, and policy messaging that together reinforce the government’s expectation that companies maintain credible, well-documented compliance programs.

For legal professionals, the significance is less about any single headline than about the aggregate signal.

The Patent Trial and Appeal Board has issued its Final Written Decision in IPR2025-00070, bringing the inter partes review to its merits-stage conclusion and giving practitioners another look at how the Board is applying patentability standards in contested post-grant proceedings. View full case on Docket Alarm

Because a Final Written Decision is the PTAB’s definitive resolution of the challenged claims and grounds that were instituted, the opinion matters well beyond the immediate dispute.